References
- Hong S, Won YJ, Park YR, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat 2020;52:335-50. https://doi.org/10.4143/crt.2020.206
- Pereira JL, Gomes M, Teixeira AL, Coelho A, Rolfo C, Araujo A. Potential and importance of metalloproteinases and interleukins in inflammation and metastasization in non-small cell lung cancer. Transl Cancer Res 2018;7:782-95. https://doi.org/10.21037/tcr.2018.05.16
- Socinski MA, Crowell R, Hensing TE, et al. Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):277S-289S. https://doi.org/10.1378/chest.07-1381
- Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer. Cochrane Database Syst Rev 2010;(5):CD007309. https://doi.org/10.1002/14651858.CD007309.pub2
- Yang JC, Wu YL, Schuler M, et al. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Lancet Oncol 2015;16:141-51. https://doi.org/10.1016/S1470-2045(14)71173-8
- Parikh RB, Cronin AM, Kozono DE, et al. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2014;89:880-7. https://doi.org/10.1016/j.ijrobp.2014.04.007
- Congedo MT, Cesario A, Lococo F, et al. Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience. J Thorac Cardiovasc Surg 2012;144:444-52. https://doi.org/10.1016/j.jtcvs.2012.05.051
- Hanagiri T, Takenaka M, Oka S, et al. Results of a surgical resection for patients with stage IV non--small-cell lung cancer. Clin Lung Cancer 2012;13:220-4. https://doi.org/10.1016/j.cllc.2011.05.006
- Endo C, Hasumi T, Matsumura Y, et al. A prospective study of surgical procedures for patients with oligometastatic non-small cell lung cancer. Ann Thorac Surg 2014;98:258-64. https://doi.org/10.1016/j.athoracsur.2014.01.052
- Johnson KK, Rosen JE, Salazar MC, Boffa DJ. Outcomes of a highly selective surgical approach to oligometastatic lung cancer. Ann Thorac Surg 2016;102:1166-71. https://doi.org/10.1016/j.athoracsur.2016.04.086
- He J, Li Y, An J, Hu L, Zhang J. Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis. World J Surg Oncol 2017;15:36. https://doi.org/10.1186/s12957-017-1105-8
- Wang Z, Gao SG, Xue Q, et al. Surgery of primary non-small cell lung cancer with oligometastasis: analysis of 172 cases. J Thorac Dis 2018;10:6540-6. https://doi.org/10.21037/jtd.2018.11.125
- Zhang C, Wang L, Li W, et al. Surgical outcomes of stage IV non-small cell lung cancer: a single-center experience. J Thorac Dis 2019;11:5463-73. https://doi.org/10.21037/jtd.2019.11.30
- Casiraghi M, Bertolaccini L, Sedda G, et al. Lung cancer surgery in oligometastatic patients: outcome and survival. Eur J Cardiothorac Surg 2020;57:1173-80. https://doi.org/10.1093/ejcts/ezaa005
- Euhus CJ, Ripley TR, Medina CG. The role of surgery for oligometastatic non-small cell lung cancer. Cancers (Basel) 2022;14:2524. https://doi.org/10.3390/cancers14102524
- Ozkaya S, Findik S, Dirican A, Atici AG. Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine. Exp Ther Med 2012;4:1035-8. https://doi.org/10.3892/etm.2012.714
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13. https://doi.org/10.1097/01.sla.0000133083.54934.ae
- Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995;13:8-10. https://doi.org/10.1200/JCO.1995.13.1.8
- Reyes DK, Pienta KJ. The biology and treatment of oligometastatic cancer. Oncotarget 2015;6:8491-524. https://doi.org/10.18632/oncotarget.3455
- Yang CJ, Gu L, Shah SA, et al. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: a national analysis. Lung Cancer 2018;115:75-83. https://doi.org/10.1016/j.lungcan.2017.11.021
- Ashworth A, Rodrigues G, Boldt G, Palma D. Is there an oligometastatic state in non-small cell lung cancer?: a systematic review of the literature. Lung Cancer 2013;82:197-203. https://doi.org/10.1016/j.lungcan.2013.07.026
- Opitz I, Patella M, Payrard L, et al. Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis. Eur J Cardiothorac Surg 2020;57:1166-72. https://doi.org/10.1093/ejcts/ezz384
- Park BJ, Shim HS, Lee CY, et al. Genetic analysis and operative outcomes in patients with oncogene-driven advanced NSCLC treated with cytoreductive surgery as a component of local consolidative therapy. Cancers (Basel) 2021;13:2549. https://doi.org/10.3390/cancers13112549
- Yuan M, Huang LL, Chen JH, Wu J, Xu Q. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther 2019;4:61. https://doi.org/10.1038/s41392-019-0099-9